ℹ️
🇬🇧
Search
Search for people relevant for "relapsed AML"
relapsed AML
Person
Class
Person
Publication
Programmes
MUDr. Petr Smíšek
External person at Second Faculty of Medicine
59 publications
Publications
publication
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study
2022 |
Publication without faculty affiliation
publication
The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01
2014 |
Publication without faculty affiliation
publication
Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group
2013 |
Publication without faculty affiliation
publication
The relapsed AML 2001/01, 02 study for children with relapsed acute myeloid leukaemia or initially resistant disease has improved outcome
2011 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
publication
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study
2024 |
Second Faculty of Medicine
publication
The effect of chemotherapy on cognitive functions in children with leukemia
2023 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Recommendations of the Czech Society of Haematology for the diagnosis and treatment of immune thrombocytopenia in adults
2023 |
Central Library of Charles University
publication
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
2022 |
Publication without faculty affiliation
publication
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach
2022 |
Publication without faculty affiliation
publication
Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS
2022 |
Publication without faculty affiliation
Load more publications (49)
Loading network view...